Baldwin Insurance Group (BWIN) Proxy filing summary

Executive summary

• A definitive agreement was reached for a majority investment by Sequence Holdings and DFO Management, taking the company private at $32.50 per share, an 88% premium to the unaffected price, valuing the transaction at $7.7 billion.

• The transaction is structured as a merger, with shareholders receiving cash and eligible employees rolling over equity into the new private entity, maintaining long-term alignment.

• The deal was unanimously approved by the board and a special committee of independent directors, with closing expected in Q1 2027, subject to shareholder and regulatory approvals.

• Upon completion, shares will be delisted from Nasdaq, and the company will operate as a wholly owned subsidiary of the new parent.

Voting matters and shareholder proposals

• Shareholders will vote on the adoption of the merger agreement and related transactions, with a proxy statement to be filed with the SEC.

• Certain stockholders and unit holders have entered into voting, support, and rollover agreements to vote in favor of the transaction and contribute or retain equity interests.

• Holders of a majority of Class B shares have already consented in writing to the transaction.

Board of directors and corporate governance

• The board established a special committee of independent, disinterested directors to evaluate and negotiate the transaction.

• The special committee and the full board unanimously determined the transaction is fair and in the best interests of unaffiliated shareholders.

• Upon closing, directors of the merger subsidiary will become directors of the surviving corporation.